Protagonist Therapeutics IncNASDAQ:PTGX
- LAST PRICE41.1100
- TODAY'S CHANGE (%)0.0700 (0.1706%)
- Bid / Lots39.9300/ 1
- Ask / Lots42.3900/ 1
- Open / Previous Close41.1700 / 41.0400
- Day Range
- 52 Week Range
- Volume1,086,776
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PTGX |
|---|---|---|
| 09:32 ET | 15807 | 40.905 |
| 09:33 ET | 2345 | 41.435 |
| 09:35 ET | 1200 | 41.045 |
| 09:37 ET | 14325 | 40.73 |
| 09:39 ET | 2300 | 41.13 |
| 09:42 ET | 600 | 40.99 |
| 09:44 ET | 844 | 40.725 |
| 09:46 ET | 240 | 40.6196 |
| 09:48 ET | 500 | 40.665 |
| 09:50 ET | 300 | 40.66 |
| 09:51 ET | 1428 | 40.86 |
| 09:53 ET | 2984 | 41.39 |
| 09:55 ET | 600 | 41.61 |
| 09:57 ET | 3201 | 41.17 |
| 10:00 ET | 1600 | 40.91 |
| 10:02 ET | 400 | 41.04 |
| 10:04 ET | 1306 | 40.675 |
| 10:06 ET | 3438 | 40.875 |
| 10:08 ET | 3068 | 40.9 |
| 10:09 ET | 920 | 40.695 |
| 10:11 ET | 1950 | 40.69 |
| 10:13 ET | 1678 | 40.665 |
| 10:15 ET | 200 | 40.56 |
| 10:18 ET | 300 | 40.44 |
| 10:22 ET | 300 | 40.39 |
| 10:24 ET | 2533 | 40.24 |
| 10:26 ET | 5122 | 40.59 |
| 10:27 ET | 1574 | 40.12 |
| 10:29 ET | 4602 | 39.9 |
| 10:31 ET | 4609 | 39.84 |
| 10:33 ET | 4468 | 40.195 |
| 10:38 ET | 623 | 40.08 |
| 10:40 ET | 1767 | 40.165 |
| 10:42 ET | 1200 | 40.22 |
| 10:44 ET | 17584 | 40.15 |
| 10:45 ET | 5190 | 40.045 |
| 10:47 ET | 18566 | 39.72 |
| 10:49 ET | 32926 | 39.88 |
| 10:51 ET | 17380 | 39.915 |
| 10:54 ET | 2909 | 39.64 |
| 10:56 ET | 28264 | 39.63 |
| 10:58 ET | 5503 | 39.875 |
| 11:00 ET | 1900 | 39.66 |
| 11:02 ET | 9827 | 39.865 |
| 11:03 ET | 1500 | 39.865 |
| 11:05 ET | 2665 | 39.865 |
| 11:07 ET | 500 | 39.855 |
| 11:09 ET | 1651 | 39.98 |
| 11:12 ET | 400 | 39.86 |
| 11:14 ET | 900 | 39.86 |
| 11:16 ET | 1903 | 40.08 |
| 11:18 ET | 1100 | 40.125 |
| 11:20 ET | 2102 | 40.125 |
| 11:21 ET | 600 | 40.19 |
| 11:23 ET | 3960 | 40.2 |
| 11:25 ET | 2688 | 40.09 |
| 11:27 ET | 1000 | 40.03 |
| 11:30 ET | 4217 | 40.04 |
| 11:32 ET | 1456 | 40.12 |
| 11:34 ET | 1100 | 40.235 |
| 11:36 ET | 1570 | 40.42 |
| 11:38 ET | 814 | 40.36 |
| 11:39 ET | 500 | 40.36 |
| 11:41 ET | 1261 | 40.48 |
| 11:43 ET | 3477 | 40.49 |
| 11:45 ET | 2248 | 40.84 |
| 11:48 ET | 471 | 40.815 |
| 11:50 ET | 1477 | 40.795 |
| 11:52 ET | 1394 | 40.77 |
| 11:54 ET | 1463 | 40.77 |
| 11:56 ET | 2559 | 40.865 |
| 11:57 ET | 2101 | 40.96 |
| 11:59 ET | 600 | 40.91 |
| 12:01 ET | 1000 | 40.91 |
| 12:03 ET | 1900 | 40.825 |
| 12:06 ET | 200 | 40.815 |
| 12:08 ET | 4927 | 40.905 |
| 12:10 ET | 700 | 40.89 |
| 12:12 ET | 405 | 40.94 |
| 12:14 ET | 3200 | 40.86 |
| 12:15 ET | 2826 | 40.815 |
| 12:17 ET | 3429 | 40.77 |
| 12:19 ET | 1145 | 40.785 |
| 12:21 ET | 3835 | 40.71 |
| 12:24 ET | 650 | 40.74 |
| 12:26 ET | 3751 | 40.675 |
| 12:28 ET | 365 | 40.675 |
| 12:30 ET | 1922 | 40.59 |
| 12:32 ET | 1212 | 40.57 |
| 12:33 ET | 2143 | 40.52 |
| 12:35 ET | 3681 | 40.57 |
| 12:37 ET | 1189 | 40.53 |
| 12:39 ET | 1200 | 40.53 |
| 12:42 ET | 1691 | 40.62 |
| 12:44 ET | 900 | 40.56 |
| 12:46 ET | 902 | 40.605 |
| 12:48 ET | 1246 | 40.56 |
| 12:50 ET | 3601 | 40.72 |
| 12:51 ET | 600 | 40.665 |
| 12:53 ET | 1419 | 40.645 |
| 12:55 ET | 4234 | 40.57 |
| 12:57 ET | 1483 | 40.63 |
| 01:00 ET | 500 | 40.62 |
| 01:02 ET | 566 | 40.615 |
| 01:04 ET | 900 | 40.65 |
| 01:06 ET | 1823 | 40.685 |
| 01:08 ET | 802 | 40.75 |
| 01:09 ET | 600 | 40.77 |
| 01:11 ET | 186 | 40.77 |
| 01:13 ET | 4565 | 40.77 |
| 01:15 ET | 815 | 40.79 |
| 01:18 ET | 3200 | 40.74 |
| 01:20 ET | 3796 | 40.71 |
| 01:22 ET | 3948 | 40.695 |
| 01:24 ET | 5126 | 40.72 |
| 01:26 ET | 1700 | 40.75 |
| 01:29 ET | 1949 | 40.865 |
| 01:31 ET | 2700 | 40.835 |
| 01:33 ET | 100 | 40.815 |
| 01:36 ET | 1247 | 40.73 |
| 01:38 ET | 1700 | 40.675 |
| 01:40 ET | 900 | 40.69 |
| 01:42 ET | 2212 | 40.75 |
| 01:44 ET | 800 | 40.795 |
| 01:45 ET | 200 | 40.78 |
| 01:47 ET | 100 | 40.735 |
| 01:49 ET | 300 | 40.715 |
| 01:51 ET | 2300 | 40.575 |
| 01:54 ET | 315 | 40.56 |
| 01:56 ET | 1505 | 40.62 |
| 01:58 ET | 700 | 40.64 |
| 02:00 ET | 700 | 40.65 |
| 02:02 ET | 1628 | 40.845 |
| 02:03 ET | 5761 | 40.7 |
| 02:05 ET | 1166 | 40.645 |
| 02:07 ET | 1823 | 40.655 |
| 02:09 ET | 200 | 40.655 |
| 02:12 ET | 2012 | 40.64 |
| 02:14 ET | 400 | 40.635 |
| 02:16 ET | 1312 | 40.605 |
| 02:18 ET | 635 | 40.605 |
| 02:20 ET | 1100 | 40.585 |
| 02:21 ET | 3201 | 40.66 |
| 02:23 ET | 1011 | 40.6 |
| 02:25 ET | 100 | 40.61 |
| 02:27 ET | 2557 | 40.725 |
| 02:30 ET | 3943 | 40.59 |
| 02:32 ET | 400 | 40.58 |
| 02:34 ET | 1975 | 40.635 |
| 02:36 ET | 800 | 40.615 |
| 02:38 ET | 1000 | 40.625 |
| 02:39 ET | 6256 | 40.665 |
| 02:41 ET | 1037 | 40.725 |
| 02:43 ET | 900 | 40.83 |
| 03:14 ET | 100 | 40.885 |
| 03:15 ET | 3996 | 40.94 |
| 03:17 ET | 304 | 40.94 |
| 03:19 ET | 410 | 40.95 |
| 03:21 ET | 882 | 40.97 |
| 03:24 ET | 3356 | 41 |
| 03:26 ET | 1502 | 41.05 |
| 03:28 ET | 4886 | 41.08 |
| 03:30 ET | 2938 | 41.025 |
| 03:32 ET | 7001 | 41.12 |
| 03:33 ET | 6152 | 41.02 |
| 03:35 ET | 2533 | 41.025 |
| 03:37 ET | 1661 | 41.085 |
| 03:39 ET | 700 | 41.1 |
| 03:42 ET | 4889 | 41.09 |
| 03:44 ET | 6123 | 40.895 |
| 03:46 ET | 2011 | 40.9 |
| 03:48 ET | 4222 | 40.88 |
| 03:50 ET | 4862 | 40.95 |
| 03:51 ET | 12140 | 40.85 |
| 03:53 ET | 9525 | 40.935 |
| 03:55 ET | 12839 | 40.99 |
| 03:57 ET | 21913 | 41.045 |
| 04:00 ET | 164401 | 41.11 |
Nov 11, 2024
DJ Protagonist Therapeutics Price Target Maintained With a $50.00/Share by HC Wainwright & Co., from 10:15AM ET on Monday Nov 11, 2024 by Dow Jones
10:15AM ET on Monday Nov 11, 2024 by Dow Jones
Nov 7, 2024
*DJ Protagonist Therapeutics 3Q Loss/Shr 54c, from 5:14PM ET on Thursday Nov 07, 2024 by Dow Jones
5:14PM ET on Thursday Nov 07, 2024 by Dow JonesProtagonist Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 4:25PM ET on Thursday Nov 07, 2024 by Dow Jones
4:25PM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
Protagonist Therapeutics Announces Poster Presentation on Final REVIVE Phase 2 Study Data with Rusfertide at the 66th Annual ASH Meeting, from 4:07PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:07PM ET on Tuesday Nov 05, 2024 by Dow JonesDJ Protagonist Therapeutics Initiated at Outperform by Wedbush, from 4:42AM ET on Tuesday Nov 05, 2024 by Dow Jones
4:42AM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Protagonist Therapeutics Inc | 2.4B | 15.4x | --- |
IDEAYA Biosciences Inc | 2.3B | -11.5x | --- |
NewAmsterdam Pharma Company NV | 2.3B | -11.1x | --- |
Iovance Biotherapeutics Inc | 2.5B | -5.5x | --- |
Scholar Rock Holding Corp | 2.5B | -11.2x | --- |
Kymera Therapeutics Inc | 2.7B | -18.0x | --- |
Company Information
Protagonist Therapeutics, Inc. is a biopharmaceutical company. The Company uses its peptide-based chemical entities rusfertide and JNJ-2113 in different stages of development, all derived from its proprietary discovery technology platform. The Company’s clinical programs fall into two categories of diseases: hematology and blood disorders, and inflammatory and immunomodulatory diseases. Its lead clinical asset, rusfertide (PTG-300), is an injectable hepcidin mimetic in development for the potential treatment of polycythemia vera (PV) and other blood disorders. The Company’s Interleukin-23 receptor (IL-23R) antagonist compound JNJ-2113 is an orally delivered investigational drug that is designed to block biological pathways targeted by marketed injectable antibody drugs. Its PN-943 is a wholly owned investigational orally delivered gut-restricted alpha 4 beta 7 (α4β7) specific integrin antagonist for inflammatory bowel disease (IBD).
Contact Information
- Headquarters
- 7707 Gateway Blvd Ste 140NEWARK, CA, United States 94560-1160
- Phone
- 510-474-0170
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Harold Selick
- President, Chief Executive Officer, Director
- Dinesh Patel
- Chief Financial Officer, Executive Vice President
- Asif Ali
- Chief Development Officer
- Suneel Gupta
- Chief Medical Officer
- Arturo Molina
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
|---|---|
Revenue (TTM) | $323.8M |
Shares Outstanding | 58.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.20 |
EPS | $2.68 |
Book Value | $5.83 |
P/E Ratio | 15.4x |
Price/Sales (TTM) | 7.5 |
Price/Cash Flow (TTM) | 14.1x |
Operating Margin | 46.05% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
